Daily Newsletter

21 August 2023

Daily Newsletter

21 August 2023

Cochlear launches next-generation bone conduction system

The Osia System represents the world's first active osseointegrated bone conduction device.

RanjithKumar Dharma August 21 2023

Hearing solutions provider Cochlear has launched its next-generation active bone conduction system, the Cochlear Osia System, which enables magnetic resonance imaging (MRI) at 3.0 teslas (T).

The new system with the Osia OSI300 implant has been developed to enhance hearing outcomes for people with mixed and conductive hearing loss and single-sided sensorineural deafness.

With the implant's introduction, Osia is the first and only active bone conduction system that enables patients to have MRI scans at both 1.5T and 3.0T without requiring surgery.

The OSI300 implant is specially developed to maintain its performance unaltered after exposure to MRI scans, unlike electromagnetic transducers, which can become demagnetised.

Contrary to axial magnets commonly present in many bone conduction implants, which are not suitable for patients undergoing an MRI at 3 T, the OSI300 deploys a diametric magnet that is housed within a casing and can rotate to align with the magnetic field of the MRI machine.

Cochlear portfolio strategy and professional marketing head Ryan Lopez said: “Not only does the new design allow for MRI scans at 3.0T without surgery or the need for a headwrap or splint kit; we have also designed the magnet cassette to be simple to remove if needed.

“The easy removal of the implant magnet reduces image artefact, an important consideration for maximum visibility of areas around the implant.”

Introduced to the market in 2020, the Osia System represents the world's first active osseointegrated bone conduction solution.

This new category of bone conduction hearing solutions deploys digital piezoelectric stimulation to bypass damaged sections of the natural hearing mechanism and transmit sound vibrations straight to the inner ear (cochlea).

Generative AI set to transform the medical devices industry

GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close